High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Abstract The purpose of this retrospective study was to compare the efficacy and toxicity of high‐dose methotrexate plus temozolomide (MT regimen) and rituximab plus MT (RMT regimen) in patients with untreated primary central nervous system lymphoma (PCNSL). A total of 62 patients with untreated PCN...

Cijeli opis

Bibliografski detalji

Glavni autori:	Cui Chen, Peng Sun, Juan Cui, Shumei Yan, Hao Chen, Yi Xia, Xiwen Bi, Panpan Liu, Yu Wang, Hang Yang, Man Nie, Xue‐Wen Zhang, Wenqi Jiang, Zhi‐Ming Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2019-04-01
Serija:	Cancer Medicine
Teme:	chemotherapy high‐dose methotrexate (HD‐MTX) primary central nervous system lymphoma (PCNSL) rituximab temozolomide (TMZ)
Online pristup:	https://doi.org/10.1002/cam4.1906
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!